In AD, lipid metabolism disturbances contribute to amyloid-beta (Aβ) aggregation and tau hyperphosphorylation, two key pathological hallmarks of the disease (Rajmohan and Reddy, 2017). Here, MAPT is linked to Alzheimer disease.